Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kazuna Tanba"'
Autor:
Yayoi Matsumura‐Kimoto, Taku Tsukamoto, Yuji Shimura, Yoshiaki Chinen, Kazuna Tanba, Saeko Kuwahara‐Ota, Yuto Fujibayashi, Daichi Nishiyama, Reiko Isa, Junko Yamaguchi, Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5185-5199 (2020)
Abstract RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL), an almost incurable disease subtype of non‐Hodgkin lymphoma. In this study, ser
Externí odkaz:
https://doaj.org/article/9e1e7146637b4917811ff4b9c406b974
Autor:
Yoshimi Mizuno, Taku Tsukamoto, Eri Kawata, Nobuhiko Uoshima, Hitoji Uchiyama, Isao Yokota, Saori Maegawa, Tomoko Takimoto, Kazuna Tanba, Yayoi Matsumura‐Kimoto, Saeko Kuwahara‐Ota, Yuto Fujibayashi, Mio Yamamoto‐Sugitani, Yoshiaki Chinen, Yuji Shimura, Shigeo Horiike, Masafumi Taniwaki, Tsutomu Kobayashi, Junya Kuroda
Publikováno v:
Cancer Medicine, Vol 7, Iss 3, Pp 655-664 (2018)
Abstract Diffuse large B‐cell lymphoma (DLBCL), which is the most prevalent disease subtype of non‐Hodgkin lymphoma, is highly heterogeneous in terms of cytogenetic and molecular features. This study retrospectively investigated the clinical impa
Externí odkaz:
https://doaj.org/article/5970ece3c6544cbb98a7014cb94e5845
Autor:
Ryo Takagi, Tsutomu Kobayashi, Shin-ichi Fuchida, Kazuho Shimura, Nobuhiko Uoshima, Hiroto Kaneko, Junya Kuroda, Yuji Shimura, Taku Tsukamoto, Katsuya Wada, Masafumi Taniwaki, Mitsushige Nakao, Miki Kiyota, Kazuna Tanba, Chihiro Shimazaki, Isao Yokota, Shigeo Horiike, Yutaka Kobayashi, Hitoji Uchiyama, Yoshiaki Chinen
Publikováno v:
Leukemia & Lymphoma. 61:3378-3386
Extended post-therapy long-term survival of patients with diffuse large B cell lymphoma (DLBCL) may also lead to an increase of late adverse events. We retrospectively investigated the frequency and clinical manifestation of second primary malignancy
Autor:
Yoshiaki Chinen, Junya Kuroda, Yuto Fujibayashi, Tsutomu Kobayashi, Reiko Isa, Daichi Nishiyama, Shigeo Horiike, Yayoi Matsumura-Kimoto, Yuji Shimura, Junko Yamaguchi, Taku Tsukamoto, Saeko Kuwahara-Ota, Yuka Kawaji-Kanayama, Masafumi Taniwaki, Kazuna Tanba
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5185-5199 (2020)
Cancer Medicine
Cancer Medicine
RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL), an almost incurable disease subtype of non‐Hodgkin lymphoma. In this study, serine‐227
Autor:
Yuji Shimura, Kazuna Tanba, Yayoi Matsumura-Kimoto, Yoshiaki Chinen, Yoshimi Mizuno, Tsutomu Kobayashi, Taku Tsukamoto, Saeko Kuwahara-Ota, Shigeo Horiike, Junya Kuroda, Shinsuke Mizutani, Tomoko Takimoto-Shimomura
Publikováno v:
Infection and Drug Resistance
Primary infection with human herpesvirus-6 (HHV-6) commonly occurs at an early age in children, most often at 3 years of age, and is associated with childhood diseases, such as exanthema subitum, hepatitis, febrile convulsions, or encephalitis. Howev
Autor:
Nobuhiko Uoshima, Shigeo Horiike, Eri Kawata, Tomoko Takimoto, Junya Kuroda, Isao Yokota, Taku Tsukamoto, Saeko Kuwahara-Ota, Yoshimi Mizuno, Saori Maegawa, Tsutomu Kobayashi, Mio Yamamoto-Sugitani, Masafumi Taniwaki, Yoshiaki Chinen, Yayoi Matsumura-Kimoto, Yuto Fujibayashi, Kazuna Tanba, Yuji Shimura, Hitoji Uchiyama
Publikováno v:
Cancer Medicine
Diffuse large B‐cell lymphoma (DLBCL), which is the most prevalent disease subtype of non‐Hodgkin lymphoma, is highly heterogeneous in terms of cytogenetic and molecular features. This study retrospectively investigated the clinical impact of G
Autor:
Taku Tsukamoto, Mio Yamamoto-Sugitani, Tsutomu Kobayashi, Saeko Kuwahara-Ohta, Yuji Shimura, Yoshiaki Chinen, Ommega Internationals, Yoshimi Mizuno, Hisao Nagoshi, Yayoi Matsumura-Kimoto, Saori Maegawa, Kazuna Tanba, Naohisa Fujita, Shinsuke Mizutani, Shigeo Horiike, Junya Kuroda
Publikováno v:
International Journal of Hematology and Therapy. 3:128-132
Autor:
Yoshiaki Chinen, Shotaro Tatekawa, Tomoko Takimoto, Shigeo Horiike, Yayoi Matsumura-Kimoto, Junya Kuroda, Tsutomu Kobayashi, Masafumi Taniwaki, Saori Maegawa, Taku Tsukamoto, Kazuna Tanba, Mio Yamamoto-Sugitani, Hisao Nagoshi, Yosuke Matsumoto, Yukari Sumida, Shinsuke Mizutani, Yuji Shimura, Yoshimi Mizuno
Publikováno v:
Internal Medicine. 55:2253-2258
We herein report a rare case of Burkitt lymphoma (BL) preceded by autoimmune hemolytic anemia (AIHA) caused by autoantibodies against D antigen. After a partial response to AIHA with prednisolone (PSL) treatment for 7 months, the patient developed BL
Autor:
Yuji Shimura, Masafumi Taniwaki, Tsutomu Kobayashi, Saori Maegawa-Matsui, Shigeo Horiike, Tomoko Takimoto-Shimomura, Yoshimi Mizuno, Kazuna Tanba, Yoshiaki Chinen, Junya Kuroda, Yuto Fujibayashi, Taku Tsukamoto, Saeko Kuwahara-Ota, Yayoi Matsumura-Kimoto
Publikováno v:
Experimental Hematology. 84:45-53.e1
Cyclin D1 (CCND1) overexpression is an early and unifying oncogenic event in mantle cell lymphoma (MCL) and multiple myeloma (MM) with chromosome 11q13 abnormalities. Herein, we report newly discovered transcript variants of the CCND1 gene in MCL and
Publikováno v:
Neuro-oncology Advances
INTRODUCTION Although the treatment outcomes of primary central nervous system lymphoma (PCNSL) with multiple treatment regimens involving high–dose methotrexate (MTX)–based multiagent chemotherapy have improved compared with the outcomes with hi